Skip to main content
. 2022 Jul 19;6(14):4196–4207. doi: 10.1182/bloodadvances.2021006885

Table 4.

Thoracic CT findings in different PcGVHD phenotypes

Thoracic CT scan findings Obstruction (N = 12) Restriction (N = 67) Mixed (N = 47) Undefined (N = 40) P
Obstructive features* Mosaic attenuation 6 (50.0) 34 (50.7) 39 (82.9) 29 (72.5) .002
Air-trapping 6 (50.0) 36 (53.7) 37 (78.7) 25 (62.5) .040
Airway thickening 4 (33.3) 17 (25.4) 29 (61.7) 16 (40.0) .001
Non-traction bronchiectasis 2 (16.7) 20 (29.9) 24 (51.1) 26 (65.0) <.001
Cystic changes 0 5 (7.5) 2 (4.3) 2 (5.0) .712
emphysema 0 2 (3.0) 3 (6.4) 0 .328
Restrictive GGO 0 27 (40.3) 31 (66.0) 7 (17.5) <.001
features*, Consolidation 0 8 (11.9) 9 (19.1) 1 (2.5) .055
Traction bronchiectasis 0 23 (34.3) 11 (23.4) 3 (7.5) .007
Lobar volume loss 0 20 (29.9) 9 (19.1) 1 (2.5) .003
Pleural abnormalities 0 29 (43.3) 16 (34.0) 4 (10.0) .002
Reticulation 0 28 (41.8) 19 (40.4) 8 (40.0) .050
PPFE 0 3 (4.5) 1 (2.1) 1 (2.5) .748
Normal* 6 (50.0%) 0 0 6 (15.0) <.001

PPFE, pleuroparenchymal fibroelastosis.

*

Number (percentage), χ2 test.

χ2 test between the RLS, M, and UD groups, without the BOS group.